Genvec (Genvec) 6-Month Price Index : N/A (As of May. 05, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Genvec 6-Month Price Index?

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2024-05-05), Genvec's 6-Month Price Index is N/A.

Competitive Comparison of Genvec's 6-Month Price Index

For the Biotechnology subindustry, Genvec's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genvec (NAS:GNVC) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index

Current Share Price

Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genvec (NAS:GNVC) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Genvec 6-Month Price Index Related Terms

Thank you for viewing the detailed overview of Genvec's 6-Month Price Index provided by GuruFocus.com. Please click on the following links to see related term pages.

Genvec (Genvec) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genvec Inc (NAS:GNVC) » Definitions » 6-Month Price Index

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.genvec.com

Genvec Inc was incorporated under the laws of the state of Delaware on December 7, 1992.The Company is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. Its development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus or RSV, herpes simplex virus or HSV, and malaria. In the area of animal health the Company is developing vaccines against foot-and-mouth disease or FMD. In collaboration with Novartis, the Companys hearing and balance disorders program is focused on the restoration of hearing and balance function through the regeneration of critical cells of the inner ear. The Company is currently developing preventative vaccines, against RSV and malaria and therapeutic vaccine against HSV.

Executives

Wayne T Hockmeyer	director	ONE MEDIMMUNE WAY, GAITHERSBURG MD 20878
Michael Richman	director	2635 TECHNOLOGY FOREST BLVD., HOUSTON TX 77381
Marc R Schneebaum	director	GENVEC, INC., 65 WEST WATKINS MILL ROAD, GAITHERSBURG MD 20878
Stefan Loren	director	3226 AVENIDA DE SUENO, CARLSBAD CA 92009
Douglas J Swirsky	director, officer: President and CEO	C/O REXAHN PHARMACEUTICALS, INC., 15245 SHADY GROVE ROAD SUITE 455, ROCKVILLE MD 20850
Willam N Kelley	director	MERCK & CO., INC., ONE MERCK DRIVE, WHITEHOUSE STATION X1 08889
Mmcap International Inc. Spc	10 percent owner	C/O MOURANT GOVERNANCE SVCS (CAYMAN) LTD, 94 SOLARIS AVE., CAMANA BAY, PO BOX 1348, GRAND CAYMAN E9 KY1-1108
Ecor1 Capital Fund Qualified, L.p.	other: See Explanation of Responses	357 TEHAMA STREET #3, SAN FRANCISCO CA 94103
Ecor1 Capital, Llc	10 percent owner	357 TEHAMA STREET #3, SAN FRANCISCO CA 94103
Oleg Nodelman	10 percent owner	357 TEHAMA STREET #3, SAN FRANCISCO CA 94103
Ecor1 Capital Fund, L.p.	other: See Explanation of Responses	357 TEHAMA STREET #3, SAN FRANCISCO CA 94103
Zola P Horovitz	director	C/O GENAERA CORP, 5110 CAMPUS DDRIVE, PLYMOUTH MEETING PA 19462
Cynthia Collins	director, officer: President & CEO	65 WEST WATKINS MILL ROAD, GAITHERSBURG MD 20878
Adel Mahmoud	director
Joshua Ruch	director	4 DUNE ROAD, EAST QUOGUE NY 11942

Genvec (Genvec) Headlines

From GuruFocus

GenVec Inc. Reports Operating Results (10-Q)

By gurufocus • 08-07-2009

GenVec Inc. Reports Operating Results (10-K)

By gurufocus 10qk • 03-11-2011

GenVec Inc. Reports Operating Results (10-Q)

By gurufocus • 05-08-2009

GenVec Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-06-2009

GenVec Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 05-07-2010